查找临床试验
已按「胆管癌」检索，对应国际通用词 cholangiocarcinoma
共找到 78 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
China
年龄 18 Years – 不限
Peking University First Hospital
Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma
China
年龄 18 Years – 不限
Tianjin Medical University Cancer Institute and Hospital
Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
China
年龄 18 Years – 不限
Chinese PLA General Hospital
A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC
China
年龄 18 Years – 75 Years
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
China
年龄 18 Years – 75 Years
Zhejiang Cancer Hospital
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
United States、China、Germany、Japan、Netherlands
年龄 18 Years – 不限
Eli Lilly and Company
Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas
China
年龄 18 Years – 75 Years
Nanfang Hospital, Southern Medical University
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
China
年龄 18 Years – 不限
Chongqing Precision Biotech Co., Ltd
Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma
China
年龄 18 Years – 75 Years
Anhui Provincial Hospital
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients
China
年龄 18 Years – 不限
Shanghai Changzheng Hospital
Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
China
年龄 18 Years – 75 Years
First Affiliated Hospital of Zhejiang University
Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma
China
年龄 18 Years – 75 Years
CNBG-Virogin Biotech (Shanghai) Ltd.